P
Prelude Therapeutics Incorporated
PRLD · NASDAQ · Healthcare · 316M
Closing price
$3.89
+0.26% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.4×
Enterprise value / EBITDAEV/EBITDA
-2.0×
Free cash flow yieldFCF yield
-18.8%
Return on equityROE
-145.0%
Operating margin
-861.3%
Net debt / EBITDAbalance-sheet strength
0.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.